Home/ Supplements/ Melatonin/ Melatonin 6 mg

Melatonin 6 mg

product on market Tablet or Pill Adaptogen Research Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Melatonin is a hormone that regulates sleep-wake cycles and is used to manage insomnia or jet lag. There is strong evidence supporting its efficacy for short-term sleep onset. This specific formulation provides a 6 mg dose to support these functions.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Melatonin 6 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

6 mg
Market median: 3.0mg (984 products) 240 studies (A:2, B:109)

Other Ingredients

Dicalcium Phosphate Cellulose Gum Stearic Acid Silicon Dioxide Ethylcellulose
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Recommended Use: As a dietary supplement, adults take 1 tablet per day twenty minutes before bedtime, or as directed by your health care practitioner.

Warnings & Precautions

Warning: Not recommended for use by pregnant or lactating women.

Keep out of reach of children.

Report any adverse reactions to 302-213-0030

Formulation Notes

Notice: Color, size or shape may appear different between lo

Vegetarian Formula

Made with Non-GMO Ingredients Does not contain gluten

Manufactured in a GMP Registered Facility in the USA

Additional Information

Store at room temperature.

Professional Use Only

Metadata

Product Details

UPC / SKU0 612524 953726
DSLD Entry Date2021-05-22
Product TypeNon-Nutrient/Non-Botanical
FormTablet or Pill
DSLD ID247128
Data Updated2026-04-11
Research

Research Evidence

291
Research Sources
55
Avg Quality
129
Meta Analysis
93
Systematic Review
51
Rct
11
Clinical Trial
2
Other
2
Regulatory Source
1
Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022 PubMed DOI
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022 PubMed DOI
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023 PubMed DOI
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Melatonin →
Compare

Similar Products

View all Melatonin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.